Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB): a new potential therapeutic target in atherosclerosis? (Q37811704)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21098861%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB): a new potential therapeutic target in atherosclerosis? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21098861%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21098861%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

3

Zbigniew Gąsior

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21098861%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1

Józefa Dąbek

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21098861%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 September 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21098861%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

published in

Pharmacological Reports

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21098861%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

62

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21098861%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21098861%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

778-783

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21098861%20AND%20SRC:MED&resulttype=core&format=json

Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Synergistic upregulation of metalloproteinase-9 by growth factors and inflammatory cytokines: an absolute requirement for transcription factor NF-kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

The two NF-kappaB activation pathways and their role in innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Regulation of M-CSF expression by M-CSF: role of protein kinase C and transcription factor NF kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Enhanced plasma levels of oxidized low-density lipoprotein increase circulating nuclear factor-kappa B activation in patients with unstable angina.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

The NF-kappaB signaling pathway in human genetic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

NF kappa B in Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Is NF-kappaB a useful therapeutic target in rheumatoid arthritis?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Cilostazol protects diabetic rats from vascular inflammation via nuclear factor-kappa B-dependent down-regulation of vascular cell adhesion molecule-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

New regulators of NF-kappaB in inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

NF-kappaB and the immune response

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

ACE inhibitor quinapril reduces the arterial expression of NF-kappaB-dependent proinflammatory factors but not of collagen I in a rabbit model of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Simvastatin reduces NF-kappaB activity in peripheral mononuclear and in plaque cells of rabbit atheroma more markedly than lipid lowering diet

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Statins differ in their ability to block NF-kB activation in human blood monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

How NF-kappaB is activated: the role of the IkappaB kinase (IKK) complex

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Inhibition of NF-kappa B by sodium salicylate and aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Inflammation meets oxidation: NF-kappaB as a mediator of initial lesion development in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Activation of nuclear factor-kappaB and correlation with elevated plasma c-reactive protein in patients with unstable angina

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Inflammation and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Lovastatin reduces nuclear factor kappaB activation induced by C-reactive protein in human vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Persistent Activation of Nuclear Factor Kappa-B Signaling Pathway in Patients With Unstable Angina and Elevated Levels of C-Reactive Protein

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Protective Role of Interleukin-10 in Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

NF-kappa B as a target for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Epoxomicin, a potent and selective proteasome inhibitor, exhibits in vivo antiinflammatory activity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Atorvastatin reduces NF-kappaB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

HMG-CoA reductase inhibitors reduce I kappa B kinase activity induced by oxidative stress in monocytes and vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Activators and target genes of Rel/NF-kappaB transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Regulation of NF-kappaB by atypical activators and tumour suppressors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IkappaB kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Angiotensin II activates nuclear transcription factor-kappaB in aorta of normal rats and in vascular smooth muscle cells of AT1 knockout mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

ACE inhibition lowers angiotensin II-induced chemokine expression by reduction of NF-kappaB activity and AT1 receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Function and activation of the transcription factor NF-kappa B in the response to toxins and pathogens

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review)

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Multiple nuclear factors interact with the immunoglobulin enhancer sequences

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

NF-kappaB activation and inhibition: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Fluvastatin inhibits the expression of tumor necrosis factor-alpha and activation of nuclear factor-kappaB in human endothelial cells stimulated by C-reactive protein

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Decreased infiltration of macrophages and inhibited activation of nuclear factor-kappa B in blood vessels: a possible mechanism for the anti-atherogenic effects of losartan

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

NF-kappa B, a potential therapeutic target for the treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

Carvedilol, a new antioxidative β-blocker, blocks in vitro human peripheral blood T cell activation by downregulating NF-κB activity

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2810%2970338-8

7 January 2021

10.1016/S1734-1140(10)70338-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21098861%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference